Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Packaging: AIRTIGHT PACKAGE
Transportation: Ocean,Land,Air,Express
Supply Ability: 5000KGS MONTHLY
Port: BEIJING,SHANGHAI,QINGDAO
In 2003, the German company Gruenenthal successfully developed a new molecular compound 3-[(1R,2R)-3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol HCL. Compared with other opioids and NSAIDs, its side effects have been improved, and the safety and tolerability of opioids have been improved. At present, 3-[(1R,2R)-3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol HCL immediate-release and sustained-release preparations have been developed and marketed in many countries to relieve moderate to severe acute or chronic pain in the central nervous system of adults.
PRODUCT 3-[(1R,2R)-3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol HCL
CAS 175591-09-0
MF C14H24ClNO
MW 257.81
Product Categories : API Intermediates > Intermediate for CAS 175591-09-0
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.